Program

15 november

9:00-10:00 Registration

09:30 – 14:00 Plenary session 1: “Stem Cells – fundamental sceince as a basis for clinical application” (Dr. Yu.V. Yurkevich , MD. M. Dominici, A.Yu. Zurabov )

09:30 – 09:40  Yu.V. Yurkevich (Dr., Professor, “Research Institute of military medicine”, Saint-Petersburg (Russia))
09:40 – 09:50  A.Yu. Zurabov  (ООО “Stem Cell Bank Pokrovskiy “, Saint-Petersburg (Russia))

09:50 – 10:30 M. Dominici. “MSC From Russia to The Entire World: Lessons Learned and New Challenges. ”
10:30 – 11:10 А.N. Tomilin “Pluripotent stem cells: from fundamental research to the clinic” (Institute of Cytology RAS, Saint-Petersburg (Russia))
11:10 – 11:40 Coffee break
11:40 – 12:20 W.D. Grimm “Extracellular Vesicles released by Neural Crest-Derived Stem Cells as a Novel Approach to Stimulate Alveolar Bone Regeneration”
12:20-13:00 E.V. Parfenova “The evolution of views on the mechanisms of regenerative processes in the heart and prospects of regenerative technologies in cardiology.” (Moscow)
13:00-13:40 Yu.V. Suhanov   “Biomedical cellular products from research to the clinic” (Moscow)
13:45-14-00 Т. Smirnova. “LIPSI: high-performance screening of living cell cultures”

14:00 – 15:00 Lunch

15:00-19:00 Plenary session 2: 

15:00 – 15:40 I.A. Baldueva “Cell technologies in immunology”
15:40 – 16:20 A.V. Averianov ” The effectiveness of cell therapy of rapidly progressive idiopathic pulmonary fibrosis is the results of a randomized placebo-controlled study.”
16:20 -16:50 Coffee break
16:50 – 17:20 P.I.Makarevich
17:20 – 17:50 A.S. Bryuhovetskiy “Stem cells in bioengineering of damaged nervous tissue”
17:50 – 18:20 D.A. Ivolgin “Prospects and possibilities of creation of research centers on the basis of private biobanks” (CSGMU, PBSK, SPb)
18:20 – 18:35 Owen Hughes. “Amnis/Merck STEM CELL RESEARCHES USING IMAGING FLOW CYTOMETRY”

16 november


15:00-19:30 sections “Preclinical research”

10:00-14:30 sections “Fundamental basis of Stem Cells opportunities”

17 november

10:00-13:30 sections “Opportunities and perspectives for stem cells application in clinical trials”